P81 What is the ideal target preterm population that might benefit from the expensive palivizumab prophylaxis? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Update in paediatric lung disease

P81 What is the ideal target preterm population that might benefit from the expensive palivizumab prophylaxis?

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Tsilika L, Batra D, Prayle A, et al

P81 What is the ideal target preterm population that might benefit from the expensive palivizumab prophylaxis?

Thorax 2017;72:A126-A127.